Active Not RecruitingNCT03540745
Nexalin electrical stimulation alongside substance use treatment
About this title
Read the official source — NCT03540745Device studyAges 18–65United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Belle MeadSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 11, 2018
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 14
- Sponsor
- University of Arizona
- Sponsor type
- University
- Study type
- Device
- Intervention type
- Device
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03540745
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Nexalin Electrical Brain Stimulation as an Adjunctive Therapy for Substance Dependence
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Belle Mead
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Arizona, a university.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
